ES2179038T3 - Fraccion porteinica para el tratamiento cosmetico y dermatologico de la piel. - Google Patents

Fraccion porteinica para el tratamiento cosmetico y dermatologico de la piel.

Info

Publication number
ES2179038T3
ES2179038T3 ES92810676T ES92810676T ES2179038T3 ES 2179038 T3 ES2179038 T3 ES 2179038T3 ES 92810676 T ES92810676 T ES 92810676T ES 92810676 T ES92810676 T ES 92810676T ES 2179038 T3 ES2179038 T3 ES 2179038T3
Authority
ES
Spain
Prior art keywords
fraction
skin
portein
cosmetic
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92810676T
Other languages
English (en)
Inventor
Rainer Vogeli
Kurt Stocker
Christian Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM Nutritional Products AG
Original Assignee
Pentapharm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm AG filed Critical Pentapharm AG
Application granted granted Critical
Publication of ES2179038T3 publication Critical patent/ES2179038T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTA UNA FRACCION PROTEINICA DE CONJUNTO DE LEGUMINOSAS, POR MEDIO DE AL MENOS UNA BANDA EN LA ELECTROFORESIS DE POLIACRILAMIDA CON NA TIVA DE 3.000 HASTA 30.000 G/MOL, UN CONTENIDO EN NITROGENO TOTAL DEL 14 HASTA EL 20% Y DE NITROGENO AMONICO DESDE EL 1 HASTA EL 2%, CON RELACION AL CONTENIDO DE PROTEINAS Y OTROS PARAMETROS DEFINIDOS EN LA SOLICITUD 1 DE PATENTE, ES ADECUADO PARA EL CUIDADO DE LA PIEL Y EN EL TRATAMIENTO DE ENFERMEDADES DE INFLAMACION DE LA PIEL. PARA ELLO SE UTILIZA LA FRACCION PROTEINICA EN LA REGULACION COMO CONCENTRADO DE SUSTANCIA ACTIVA O POR EJEMPLO COMO CREMA, LOCION, EMULSION, GEL, MASCARA DE LA CARA, POLVO O EMPLASTO.
ES92810676T 1991-09-13 1992-09-03 Fraccion porteinica para el tratamiento cosmetico y dermatologico de la piel. Expired - Lifetime ES2179038T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH270591 1991-09-13

Publications (1)

Publication Number Publication Date
ES2179038T3 true ES2179038T3 (es) 2003-01-16

Family

ID=4239747

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92810676T Expired - Lifetime ES2179038T3 (es) 1991-09-13 1992-09-03 Fraccion porteinica para el tratamiento cosmetico y dermatologico de la piel.

Country Status (6)

Country Link
US (1) US5322839A (es)
EP (1) EP0532465B1 (es)
JP (1) JP3333243B2 (es)
KR (1) KR100271392B1 (es)
DE (1) DE59209963D1 (es)
ES (1) ES2179038T3 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547997A (en) * 1991-10-01 1996-08-20 Chemisches Laboratorium Dr. Kurt Richter Gmbh Plant-derived cosmetic composition and method of treatment of skin
GB9409281D0 (en) 1994-05-10 1994-06-29 Svedman Paul Transdermal device
US6030620A (en) * 1997-07-25 2000-02-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing an organic extract of chick pea
US8039026B1 (en) * 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
EP0898962A1 (en) * 1997-08-28 1999-03-03 Becton, Dickinson and Company Transdermal patches and methods for inactivating skin proteases
DE19801593A1 (de) * 1998-01-17 1999-07-22 Henkel Kgaa Lipoprotein-Cremes
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
JP2002541082A (ja) * 1999-03-31 2002-12-03 ペンタファルム アクチェンゲゼルシャフト 化粧品学的および皮膚科学的スキンケア用組成物
FR2796839B1 (fr) * 1999-07-26 2003-05-23 Serobiologiques Lab Sa Utilisation d'une fraction proteique de la graine de la plante vigna trilobata dans une composition cosmetique ou dermopharmaceutique
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
DE19950019A1 (de) * 1999-10-16 2001-04-19 Henkel Kgaa Tensidhaltige Reinigungsmittel mit Enzym-Inhibitoren
AU2012216795B2 (en) * 1999-11-05 2015-07-09 Johnson & Johnson Consumer Companies, Inc. Soy depigmenting and skin care compositions
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
PL202189B1 (pl) * 2000-02-21 2009-06-30 Fraunhofer Ges Forschung Sposób otrzymywania preparatów białkowych o w daleko idącej mierze niezmiennych, użytkowo technicznych właściwościach funkcyjnych w szerokim zakresie-pH od około pH=3 do pH=10
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
FR2811226B1 (fr) * 2000-06-05 2003-06-20 Clarins Laboratoires S A S Composition cosmetique hydratante comprenant un inhibiteur de trypsine vegetal
KR100385417B1 (ko) * 2000-06-22 2003-05-27 주식회사 건양기술공사 건축사사무소 하수 및 오수내 비오디의 고도처리장치
FR2811894B1 (fr) * 2000-07-19 2003-01-10 Serobiologiques Lab Sa Utilisation de fractions proteiniques solubles pour la stimulation de la synthese de filaggrine
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
EP1281392A1 (de) * 2001-08-02 2003-02-05 Cognis France S.A. Kosmetische und/oder pharmaceutische Zubereitungen enthaltend Pflanzenextrakte
EP1310261A1 (de) 2001-11-09 2003-05-14 Cognis France S.A. Verwendung eines Extraktes der Vigna aconitifolia-Pflanze in einer Kosmetischen und/oder dermopharmazeutischen Zusammensetzung
GB0127554D0 (en) * 2001-11-16 2002-01-09 Syngenta Participations Ag Organic compounds
US20030224075A1 (en) * 2002-02-21 2003-12-04 Jue-Chen Liu Soy composition for balancing combination skin
WO2003106486A1 (de) * 2002-06-12 2003-12-24 Fraunhofer-Gelellschaft Zur Förderung Der Angewandten Forschung E.V. Pflanzliche proteinpräparate und deren verwendung
US20040063593A1 (en) * 2002-09-30 2004-04-01 Wu Jeffrey M. Compositions containing a cosmetically active organic acid and a legume product
FR2854799A1 (fr) * 2003-05-16 2004-11-19 Cognis France Sa Utilisation d'extraits des graines de plantes appartenant au genre adenanthera pour la fabrication de preparations cosmetiques et/ou dermatologiques
US6957842B1 (en) * 2004-04-30 2005-10-25 Asc Incorporated Convertible roof bow tensioning apparatus
JPWO2006052003A1 (ja) * 2004-11-11 2008-05-29 オルガノ株式会社 エンドウホエー由来の可溶性ポリペプチド、発泡剤及びその製造方法
JP4160964B2 (ja) 2005-04-01 2008-10-08 株式会社ファンケル スイートピー抽出物含有化粧料
JP4886358B2 (ja) * 2006-05-11 2012-02-29 オルガノ株式会社 エンドウホエー由来の可溶性ポリペプチドを有効成分とする起泡剤およびこれを含む炭酸飲料
US20080152592A1 (en) * 2006-12-21 2008-06-26 Bayer Healthcare Llc Method of therapeutic drug monitoring
WO2008115224A2 (en) * 2007-03-20 2008-09-25 Bayer Healthcare Llc Method of analyzing an analyte
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
FR2953136B1 (fr) 2009-11-30 2012-05-11 Expanscience Lab Extrait de graines de vigna unguiculata et compositions cosmetiques, pharmaceutiques, dermatologiques, nutraceutiques ou alimentaires le comprenant
WO2016005243A1 (de) * 2014-07-08 2016-01-14 Henkel Ag & Co. Kgaa Schweisshemmende kosmetische mittel mit speziellen proteinen aus hülsenfrüchten der gattung pisum und/oder phaseolus und/oder vigna und/oder macrotyloma oder aus kreuzblütengewächsen der gattung brassica, welche keine halogenide und/oder hydroxyhalogenide von aluminium und/oder zirconium enthalten
KR102518581B1 (ko) * 2017-11-29 2023-04-06 (주)아모레퍼시픽 방울양배추, 리마콩 및 아티초크의 해수 복합추출물을 유효성분으로 포함하는 화장료 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2794800A (en) * 1954-01-06 1957-06-04 Armour & Co Preparation of antitryptic substance from soybean
LU76955A1 (es) * 1977-03-15 1978-10-18
JPS60202806A (ja) * 1984-03-26 1985-10-14 Sansho Seiyaku Kk 色白化粧料
CS275231B2 (en) * 1989-09-29 1992-02-19 Ustav Makormolekularni Chemie Medicine bottle

Also Published As

Publication number Publication date
KR930006049A (ko) 1993-04-20
JP3333243B2 (ja) 2002-10-15
EP0532465B1 (de) 2002-07-10
DE59209963D1 (de) 2002-08-14
KR100271392B1 (ko) 2000-11-15
EP0532465A1 (de) 1993-03-17
JPH05230100A (ja) 1993-09-07
US5322839A (en) 1994-06-21

Similar Documents

Publication Publication Date Title
ES2179038T3 (es) Fraccion porteinica para el tratamiento cosmetico y dermatologico de la piel.
ES2102921T3 (es) Utilizacion de derivados de la hormona estimuladora de los melanocitos de tipo alfa para estimular el crecimiento de los cabellos.
ES2108110T3 (es) Composiciones terapeuticas y cosmeticas para el tratamiento de la piel.
ATE196600T1 (de) Kosmetische zubereitungen enthaltend extrakte von phyllanthus emblica und centella asiatica und/oder bacopa monnieri
ES2145143T3 (es) Copolimeros elastomericos termoplasticos y composiciones que los contienen para el cuidado del cabello y de la piel.
IL77096A (en) Pharmaceutical compositions for enhancing wound healing comprising angiogene and growth factors
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
ES2136739T3 (es) Copolimeros elastomeros termoplasticos injertados de silicona y composiciones para el cuidado del cabello y de la piel que los contienen.
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
ATE200419T1 (de) Haut- und/oder haardepigmentierungsmittel
ATE17186T1 (de) Kosmetisches praeparat.
ES2042749T3 (es) Producto para el tratamiento del cabello.
DE50310486D1 (de) Lipid-transferprotein - systeme und deren kosmetische dermatologische anwendung
ATE143276T1 (de) Transdermales system mit gestufter wirkstoffabgabe und verwendung für die lokale oder systemische, kosmetische wirkstoffverabreichung
GR3032278T3 (en) Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics.
AU1439199A (en) Use of a diphenyldimethicone dissolved in a non-volatile silicone such as phenyltrimethicone for making a cosmetic or pharmaceutical, in particular dermatological, composition comprising a fatty phase
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
MY110263A (en) Reservoir for controlled active substance delivery, apparatus containing the same, as well as method for its manufacture and use of the apparatus.
AR229194A1 (es) Esteres de biotina,composicion cosmetica para el cuidado del cabello o de la piel y procedimiento para la preparacion de dichos esteres de biotina
FR2679449B1 (fr) Nouvelles preparations cosmetiques antiprurigineuses contenant un extrait de racines d'harpagophyton.
RU93026473A (ru) Косметический крем
RU93026474A (ru) Косметический крем
IT1225405B (it) Formulazione cosmetica per la cura della pelle.
CO4230067A1 (es) Composicion cosmetica para el cuidado de la piel
RU93026471A (ru) Косметический крем